Research3 days ago 5 min read
Thymosin Alpha-1 reduces severe infections in elderly cohort
A two-year observational study followed 800 nursing home residents.
by Editorial team
The study
Researchers followed 800 nursing home residents over two years, with about half receiving twice-weekly Thymosin Alpha-1 injections.
Outcomes included hospitalization for infection, antibiotic days, and mortality.
Results
The Thymosin Alpha-1 group had 26% fewer hospitalizations for infection and fewer antibiotic days.
Mortality differences trended in favor of treatment but did not reach statistical significance.
Important caveats
This was an observational study, not a randomized trial.
Selection bias and confounding cannot be fully ruled out.
